Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) announced that it has refiled its condensed interim consolidated financial statements and…
Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has announced that, after review, it will refile its condensed interim consolidated financial…
Champignon Brands’ (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Chairman, Dr. Roger McIntyre, today announced changes to its board of directors.…
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) today announced the publication of an article led by its CEO Dr.…
Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a research-driven company specializing in breakthrough ketamine treatment for depression and other…
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) chairman and CEO Roger McIntyre today announced the company's appointment of Stephen R.…
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) today announced the publication of an article led by Dr. Roger McIntyre, CEO…
Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has announced that its executive leadership team will be changing; these changes…
Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has provided an update on its efforts to resolve a continuous disclosure review…
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), today announced the election of Dr. Roger McIntyre as chairman of its…